Session Information

WCLC 2017

18th World Conference on Lung Cancer

Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan

Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.
Presentation Date(s):
- Oct 15 - 18, 2017
- Total Presentations: 2295
Register to Attend WCLC Return to WCLC 2017 Website Switch to Virtual Meeting
Enter Virtual Meeting Access Code

All Days Saturday
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18

Filter Results:

Show Only CME Accredited Sessions

20163

+
P1.14 - Radiotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
- 22777
  
  +
  
  P1.14-010 - SGA Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients Treated by Concurrent Chemoradiotherapy
  
  09:30 - 09:30 | Presenter: Hui Liu | Author(s): L. Ma, W. Ye, Q. Li, B. Wang, G. Luo, Z. Chen, S. Guo, Bo Qiu
  Abstract
  
  Loading...
- 22778
  
  +
  
  P1.14-011 - An Esophagus-Sparing Technique to Limit Radiation Esophagitis in Locally Advanced NSCLC Treated by SIB-IMRT and Concurrent Chemotherapy
  
  09:30 - 09:30 | Presenter: Hui Liu | Author(s): L. Ma, Q. Li, L. Chen, M. Lin, B. Wang, Y. Hu, M. Liu, Li Zhang, Y. Huang, X. Deng, Y. Xia, B. Qiu
  Abstract
  
  Loading...
20171

+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
- 23387
  
  +
  
  P2.07-012 - Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
  
  09:30 - 09:30 | Presenter: Martin Früh | Author(s): S. Schmid, S. Diem, M. Krapf, Q. Li, L. Flatz, S. Leschka, L. Desbiolles, D. Klingbiel, W. Jochum
  Abstract
  
  Loading...
20178

+
P2.14 - Radiotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
- 23499
  
  +
  
  P2.14-004 - Comparable Local Controls after Twice-Daily and Once-Daily Chest Radiotherapy in Extensive Stage Small Cell Lung Cancer
  
  09:30 - 09:30 | Presenter: Bo Qiu | Author(s): Q. Li, W. Xie, Z. Hui, B. Wang, Y. Liang, J. Guo, Y. Zhou, M. Zhu, W. Shen, R. Duan, L. Chen, Li Zhang, H. Long, Hui Liu
  Abstract
  
  Loading...
20130

+
MA 09 - The Current Status of Radiation Oncology
- 11:00 - 12:30
- 10/17/2017
- Location: Room 316
- Type: Mini Oral
- Track: Locally Advanced NSCLC
- Moderators:Tomoki Kimura, Yong Chan Ahn
- 23587
  
  +
  
  MA 09.01 - A Propensity-Matched Analysis of Lobectomy and Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer
  
  11:00 - 11:05 | Presenter: Yaping Xu | Author(s): Q. Lin, X. Sun, J. Liu, Q. Chen, W. Mao
  Abstract
  
  Loading...
20134

+
MA 15 - Lung Cancer Biology II
- 15:45 - 17:30
- 10/17/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:H. Akita
- 23750
  
  +
  
  MA 15.11 - CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09)
  
  16:55 - 17:00 | Presenter: Sacha I Rothschild | Author(s): M. Amrein, C. Riether, O. Gautschi, N. Schuster, Q. Li, Spasenija Savic, M. Schneider, C. Biaggi, Lukas Bubendorf, M. Brutsche, A. Zippelius, T. Zander, D. Betticher, Martin Früh, Rolf A Stahel, R. Cathomas, D. Rauch, M. Pless, A. Ochsenbein, R. Jaggi
  Abstract
  
  Loading...
20139

+
MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches
- 15:45 - 17:30
- 10/17/2017
- Location: Room 313 + 314
- Type: Mini Oral
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:K. Shibuya, Francoise Mornex
- 23767
  
  +
  
  MA 16.13 - PD-L1 Expression Is a Prognostic Factor in Patients with Esophageal Squamous Cell Carcinoma Treated with Postoperative Adjuvant Radiotherapy
  
  17:05 - 17:10 | Presenter: Yaping Xu | Author(s): C. Jiang, S. Han, H. Wu, Q. Lin, J. Hu, G. Zhang
  Abstract
  
  Loading...
- 23768
  
  +
  
  MA 16.14 - c-Met in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Potential Therapeutic Target
  
  17:10 - 17:15 | Presenter: Yaping Xu | Author(s): C. Jiang, S. Han, G. Lin, X. Zhu, J. Feng, G. Zhang, Q. Lin
  Abstract
  
  Loading...
18975

+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
- 23917
  
  +
  
  P3.01-058 - Impact of Different Timing of Radiotherapy in Patients with Brain Metastases from Epidermal Growth Factor Receptor-Mutant NSCLC
  
  09:30 - 09:30 | Presenter: Yaping Xu | Author(s): X. Ying, S. Han, Q. Lin, J. Fang, X. Sun
  Abstract
  
  Loading...
20193

+
P3.14 - Radiotherapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
- 24205
  
  +
  
  P3.14-015 - A Propensity Matched Analysis of SBRT and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in Patients at High Risk for Lobectomy
  
  09:30 - 09:30 | Presenter: Yaping Xu | Author(s): W. Chen, Q. Lin, X. Sun, J. Liu, Q. Chen, W. Mao
  Abstract
  
  Loading...
20196

+
P3.17 - Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- 24279
  
  +
  
  P3.17-003 - A Selective Small Molecule Inhibitor of C-Met Kinase, BPI-9016M, Has Synergistic Effects with Radiation on Esophageal Squamous Cell Carcinoma
  
  09:30 - 09:30 | Presenter: Yaping Xu | Author(s): C. Jiang, S. Han, G. Lin, F. Gu, Q. Lin, J. Feng
  Abstract
  
  Loading...
20150

+
OA 16 - Treatment Strategies and Follow Up
- 14:30 - 16:15
- 10/18/2017
- Location: Room 315
- Type: Oral
- Track: Early Stage NSCLC
- Moderators:Jun Nakajima, T. Demmy
- 24431
  
  +
  
  OA 16.04 - Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients
  
  15:00 - 15:10 | Presenter: Dongsheng Yue | Author(s): S. Xu, Q. Wang, X. Li, Y. Shen, H. Zhao, C. Chen, W. Mao, W. Liu, J. Liu, L. Zhang, H. Ma, Q. Li, Y. Yang, Y. Liu, H. Chen, C. Wang
  Abstract
  
  Loading...

Session Information

WCLC 2017

18th World Conference on Lung Cancer

Enter Virtual Meeting Access Code

+

P1.14 - Radiotherapy

+

P1.14-010 - SGA Could Be a Predictive Factor for Radiation Pneumonitis in Lung Cancer Patients Treated by Concurrent Chemoradiotherapy

+

P1.14-011 - An Esophagus-Sparing Technique to Limit Radiation Esophagitis in Locally Advanced NSCLC Treated by SIB-IMRT and Concurrent Chemotherapy

+

P2.07 - Immunology and Immunotherapy

+

P2.07-012 - Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)

+

P2.14 - Radiotherapy

+

P2.14-004 - Comparable Local Controls after Twice-Daily and Once-Daily Chest Radiotherapy in Extensive Stage Small Cell Lung Cancer

+

MA 09 - The Current Status of Radiation Oncology

+

MA 09.01 - A Propensity-Matched Analysis of Lobectomy and Stereotactic Body Radiotherapy for Early Stage Non-Small Cell Lung Cancer

+

MA 15 - Lung Cancer Biology II

+

MA 15.11 - CCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19/09)

+

MA 16 - Mediastinal, Tracheal and Esophageal Tumor: Multimodality Approaches

+

MA 16.13 - PD-L1 Expression Is a Prognostic Factor in Patients with Esophageal Squamous Cell Carcinoma Treated with Postoperative Adjuvant Radiotherapy

+

MA 16.14 - c-Met in Esophageal Squamous Cell Carcinoma: An Independent Prognostic Factor and Potential Therapeutic Target

+

P3.01 - Advanced NSCLC

+

P3.01-058 - Impact of Different Timing of Radiotherapy in Patients with Brain Metastases from Epidermal Growth Factor Receptor-Mutant NSCLC

+

P3.14 - Radiotherapy

+

P3.14-015 - A Propensity Matched Analysis of SBRT and Sublobar Resection for Stage I Non-Small Cell Lung Cancer in Patients at High Risk for Lobectomy

+

P3.17 - Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies

+

P3.17-003 - A Selective Small Molecule Inhibitor of C-Met Kinase, BPI-9016M, Has Synergistic Effects with Radiation on Esophageal Squamous Cell Carcinoma

+

OA 16 - Treatment Strategies and Follow Up

+

OA 16.04 - Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients

Stay Connected